The Launch of PROTEOMICS ‐ Clinical Applications
The Launch of PROTEOMICS ‐ Clinical Applications
复制标题
DOI：
10.1002/prca.200790000
复制
发表时间：
2006-07
期刊：
影响因子：
--
通讯作者：
M. Dunn
中科院分区：
文献类型：
--
作者：
M. Dunn
蛋白质组学家族期刊的唯一成员。《蛋白质组学-临床应用》的目标是成为蛋白质组学在人类疾病研究和临床应用领域的主要信息来源。该杂志将发表临床蛋白质组学所有相关领域的论文，包括：基础蛋白质组学研究旨在进一步了解人类疾病功能障碍的分子机制，蛋白质组学研究的结果致力于发现和验证诊断和预后疾病生物标志物，使用蛋白质组学发现新的药物靶点，蛋白质组学在药物开发管道中的应用，以及将蛋白质组学用作临床试验的组成部分。这份新杂志将于2007年每月出版一次，并将有自己的政策和编辑委员会。《蛋白质组学》母刊的一些高级编辑加入了四位新的高级编辑，Gilbert Omenn (Ann Arbor， MI， USA)， O. John Semmes (Norfolk， VA， USA), Roz Banks （Leeds， UK）和Timothy Veenstra (Frederick， MD， USA)，他们都对临床蛋白质组学有特别的兴趣。编辑委员会在临床蛋白质组学领域的专业知识大大加强了二十多名新成员的任命，他们的研究兴趣集中在这一领域。虽然将在2007年出版的12期《蛋白质组学-临床应用》中的大多数将是常规刊物，但我们也将制作专刊，专门收集有关临床蛋白质组学重要和新兴领域的论文。这些特刊的第一期将作为第8期（2007年8月）出版，罗兹·班克斯（英国利兹）将担任客座编辑，并将重点关注体液。我们还计划出版一期关于临床蛋白质组学热点的综述（第9期，2007年9月）。《蛋白质组学-临床应用》前三卷即将出版的未来特刊包括神经蛋白质组学（Gert Lubec）、心血管蛋白质组学（Jennifer Van Eyk和Manuel Mayr）、生物银行和预分析方面（Denis Hochstrasser和Scott Patterson）、肾脏和泌尿蛋白质组学（Visith Thongboonkerd）、蛋白质组学与化学遗传学在药物作用和作用分析中的比较（Bill Jordan）和癌症蛋白质组学（Serhiy Souchelnytskyi）。
alone member of the PROTEOMICS Family of journals. The aim of PROTEOMICS–Clinical Applications is to be the premier source of information in the field of the application of proteomics to the study of human disease and translation to the clinic. The journal will publish papers in all relevant areas of clinical proteomics including: basic proteomic research designed to further understanding of the molecular mechanisms underlying dysfunction in human disease, the results of proteomic studies dedicated to the discovery and validation of diagnostic and prognostic disease biomarkers, the use of proteomics for the discovery of novel drug targets, the application of proteomics in the drug development pipeline, and the use of proteomics as a component of clinical trials.The new journal will be published monthly during 2007 and will have its own policy and editorial boards. Some of the Senior Editors of the PROTEOMICS mother journal are joined by four new Senior Editors, Gilbert Omenn (Ann Arbor, MI, USA), O. John Semmes (Norfolk, VA, USA), Roz Banks (Leeds, UK) and Timothy Veenstra (Frederick, MD, USA), all of whom have a particular interest in clinical proteomics. The expertise of the Editorial Board in the area of clinical proteomics is considerably strengthened by the appointment of more than twenty new members whose research interests are focused in this area. While the majority of the 12 issues of PROTEOMICS–Clinical Applications that will be published during 2007 will be regular issues, we will also be producing Special Issues devoted to collections of papers devoted to important and emerging areas of clinical proteomics. The first of these Special Issues, to be published as issue 8 (August 2007) will have Roz Banks (Leeds, UK) as Guest Editor and will focus on Body Fluids. We have also planned to publish an issue devoted to reviews of hot topics in clinical proteomics (issue 9, September 2007). Future Special Issues that are still in the planning stage to be published in the first three volumes of PROTEOMICS–Clinical Applications include Neuroproteomics (Gert Lubec), Cardiovascular Proteomics (Jennifer Van Eyk and Manuel Mayr), Biobanking and Pre-analytical Aspects (Denis Hochstrasser and Scott Patterson), Renal and Urinary Proteomics (Visith Thongboonkerd), Comparison of Proteomics and Chemical Genetics for Analysis of Drug Effects and Actions (Bill Jordan) and Cancer Proteomics (Serhiy Souchelnytskyi).